Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogens

Cellular and Molecular Life Sciences

Volumn 61, Issue 1, 2004, Pages 76-82

  Coradini, D ^a   Pellizzaro, C ^a   Speranza, A ^a   Daidone, M G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Breast cancer cell line; Estradiol; HIF 1 ; Tamoxifen; VEGF

Indexed keywords

ANTIESTROGEN; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; ISOPROTEIN; STEROID HORMONE; TAMOXIFEN; VASCULOTROPIN;

ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL STIMULATION; CELL STRAIN MCF 7; DRUG RESPONSE; HORMONAL THERAPY; HUMAN; HUMAN CELL; HYPOXIA; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; STATISTICAL SIGNIFICANCE; STIMULUS;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CELL HYPOXIA; COBALT; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; RECEPTORS, ESTROGEN; TAMOXIFEN; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MINK CELL FOCUS-FORMING VIRUS;

EID: 1642540250     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-003-3324-0     Document Type: Article

References (20)

1. Katzenellenbogen B. S., Montano M. M., Ekena K., Herman M. E. and McInerney E. M. (1997) William McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer. Breast Cancer Res. Treat. 44: 23-38
2. Foekens J. A., Peters H. A., Grebenchtchikov N., Look M. P., Meijer-van Gelder M., Geurts-Moespot A. et al. (2001) High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer. Cancer Res. 61: 5407-5414
3. Coradini D., Biganzoli E., Pellizzaro C., Veneroni S., Oriana S., Ambrogi F. et al. (2003) Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen. Br. J. Cancer 89: 268-270
4. Shweiki D., Itin A., Soffer D. and Keshet E. (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359: 843-845
5. Folkman J. (2002) Role of angiogenesis in tumor growth and metastasis. Sem. Oncol. 29: 15-18
6. Mueller M. D., Vigne J.-L., Minchenko A., Lebovic D. I., Leitman D. C. and Taylor R. N. (2000) Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β. Proc. Natl. Acad. Sci. USA 97: 10972-10977
7. Kuiper G. J. M., Enmark E., Pelto-Hukko M., Nilsson S. and Gustafsson J.-A. (1996) Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93: 5925-5930
8. Katzenellenbogen B. S., Choi I., Delage-Mourroux R., Ediger T. R., Martini P. G. V., Montano M. et al. (2000) Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. J. Steroid Biochem. Mol. Biol. 74: 279-285
9. Yuan Y., Hulliard G., Ferguson T. and Millhorn D. E. (2003) Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α. J. Biol. Chem. 278: 15911-15916
10. Mann S., Laucirica R., Carlson N., Younes P. S., Ali N. and Younes A. (2001) Estrogen receptor beta expression in invasive breast cancer. Hum. Pathol. 32: 113-118
11. Pellizzaro C., Coradini D. and Daidone M. G. (2002) Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29. Carcinogenesis 23: 735-740
12. Drewinko B., Loo T. L., Brown B., Gottlieb J. A. and Freireich E. J. (1976) Combination chemotherapy in vitro with adriamycin: observations of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells. Cancer Biochem. Biophys. 1: 187-195
13. Bhuyan B. K., Adams E. G., Johnson M. and Crampton S. L. (1985) Synergistic combination of menogarol and malphalan and two other drug combinations. Invest. New Drugs 3: 233-244
14. Vladusic E. A., Hornby A. E., Guerra-Vladusic F. K., Lakins J. and Lupu R. (2000) Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. Oncol. Rep. 7: 157-167
15. Cappelletti V., Saturno G., Miodini P., Korner W. and Daidone M. G. (2003) Selective modulation of ER-β by estradiol and xenoestrogens in human breast cancer cell lines. Cell Mol. Life Sci. 60: 567-576
16. Saville B., Wormke M., Wang F., Nguyen T., Enmark E., Kuiper G. et al. (2000) Ligand-, cell-, and estrogen receptor subtype (α/β)-dependent activation at GC-rich (Sp1) promoter elements. J. Biol. Chem. 275: 5379-5387
17. Li L.-C., Yeh C.-C., Nojima D. and Dahiya R. (2000) Cloning and characterization of human estrogen receptor β promoter. Biochem. Biophys. Res. Commun. 275: 682-689
18. Wen X.-F., Shen Z., Shen Z.-Z., Nguyen M. and Shao Z.-M. (2002) The expression of ERβ protein correlates with vascular endothelial growth factor and its prognostic significance in human breast cancer. Oncol. Rep. 9: 937-944
19. Buteau-Lozano H., Ancelin M., Lardeux B., Milanini J. and Perrot-Applanat M. (2002) Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors α and β. Cancer Res. 62: 4977-4984
20. Miyamoto N., Mandai M., Takagi H., Suzuma I., Suzuma K., Koyama S. et al. (2002) Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP. Invest. Ophthalmol. Vis. Sci. 43: 2007-2014